Denise P. Carter, Chief Operating Officer at Quoin Pharmaceuticals, Ltd. (QNRX), bought 20,490 shares at $4.88 ($100K) on 2026-08-31, disclosed to the SEC on 2026-09-01.
Quoin Pharmaceuticals COO Denise P. Carter purchased 20,490 shares at $4.88 on August 31, 2026, signaling confidence in the stock's recent surge. This buy comes as the shares have rallied nearly 50% over the last 30 days, suggesting the insider is positioning for further upside.
QNRX shares have surged 49.66% over the last 30 days, trading at $6.54, which is 88.74% above its 52-week low of $3.465 but still down 11.33% from its 52-week high of $41.8.
Coming off a 126% intraday jump on October 10, 2025, following a $104.5 million private placement announcement, the stock remains volatile. Insiders have significantly increased their holdings over the last year, with one insider upping their stake by 1,515,200% as of January 23, 2026.
The stock is highly volatile with a beta of 1.659 and recently faced sector-wide pressure, with healthcare stocks declining late in the day on August 28, 2026. Additionally, the company has a short interest of 5.56% of the float, which could exacerbate price swings.
Something here stands out, but not much.
| Filing → |